Sozo Ventures GP II, L.P.

In its 13F for Q3 2025 (holdings as of September 30, 2025, filed November 6, 2025), Sozo Ventures GP II, L.P. reported 1 stock position worth $1.3 million. Its top holding was Metagenomi Therapeutics (MGX) at 100.0% of the portfolio. Its holdings were unchanged from Q2 2025.

Most Recent 13F
Q3 2025
Location
REDWOOD CITY, CA
CIK
0001912294
Portfolio Value
$1.3M (Q3 2025)
SEC Filing
0001104659-25-107211 ↗ filed Nov 6, 2025

Holdings Value

0$100.0M$200.0M$300.0M Q1 2024: $293.8M Q1 2024 Q2 2024: $243.5M Q2 2024 Q3 2024: $194.6M Q3 2024 Q4 2024: $2.1M Q4 2024 Q1 2025: $1.0M Q1 2025 Q2 2025: $861K Q2 2025 Q3 2025: $1.3M $1.3M Q3 2025

Holdings 1 stocks · $1.3M

MGX Metagenomi Therapeutics Inc. 100.00% 581,577 $1.3M No change

Portfolio Sells Q2 2025 → Q3 2025

None this quarter.

Portfolio Buys Q2 2025 → Q3 2025

None this quarter.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q3 2025 1$1.3MMGX
Q2 2025 1$861KMGX
Q1 2025 1$1.0MMGX
Q4 2024 1$2.1MMGX
Q3 2024Amended 2$194.6MCOIN, MGX
Q2 2024Amended 2$243.5MCOIN, MGX
Q1 2024Amended 2$293.8MCOIN, MGX